{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:43:11Z","timestamp":1792669391480,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Metab"],"DOI":"10.1038\/s42255-026-01603-y","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:03:38Z","timestamp":1789376618000},"page":"2069-2083","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cagrilintide and retatrutide combination therapy enhances weight loss and metabolic outcomes in obese male rats"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6219-0271","authenticated-orcid":false,"given":"Jonas","family":"Petersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5076-1534","authenticated-orcid":false,"given":"Christoffer","family":"Merrild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9628-8285","authenticated-orcid":false,"given":"Stephanie Kj\u00e6rulff","family":"Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5011-0297","authenticated-orcid":false,"given":"Nigel","family":"Kurgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9751-0098","authenticated-orcid":false,"given":"Shad","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8325-5898","authenticated-orcid":false,"given":"Cecilie Vad","family":"Mathiesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3942-5324","authenticated-orcid":false,"given":"Stina","family":"B\u00f6rchers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8329-319X","authenticated-orcid":false,"given":"Charlotte","family":"Svendsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1349-5157","authenticated-orcid":false,"given":"Sergio","family":"D\u2019Anna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1512-2727","authenticated-orcid":false,"given":"Nicoline R.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders Bue","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8793-9739","authenticated-orcid":false,"given":"Andreas M.","family":"Fritzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2278-1843","authenticated-orcid":false,"given":"Atul S.","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0207-4831","authenticated-orcid":false,"given":"Tune H.","family":"Pers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2456-9667","authenticated-orcid":false,"given":"Christoffer","family":"Clemmensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"1603_CR1","doi-asserted-by":"publisher","unstructured":"Petersen, J., Finan, B., Johansen, V. B. I., M\u00fcller, T. D. & Clemmensen, C. The evolving landscape of obesity pharmacotherapy. Nat. Rev. Drug Discov. 25, 619\u2013647 https:\/\/doi.org\/10.1038\/s41573-026-01427-1 (2026).","DOI":"10.1038\/s41573-026-01427-1"},{"key":"1603_CR2","doi-asserted-by":"publisher","unstructured":"Johansen, V. B. I. et al. Brain control of energy homeostasis: implications for anti-obesity pharmacotherapy. Cell 188, 4178\u20134212 https:\/\/doi.org\/10.1016\/j.cell.2025.06.010 (2025).","DOI":"10.1016\/j.cell.2025.06.010"},{"key":"1603_CR3","unstructured":"Lilly\u2019s triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial. Eli Lilly and Company https:\/\/investor.lilly.com\/news-releases\/news-release-details\/lillys-triple-agonist-retatrutide-delivered-powerful-weight-loss (2026)."},{"key":"1603_CR4","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1056\/NEJMoa2502081","volume":"393","author":"WT Garvey","year":"2025","unstructured":"Garvey, W. T. et al. Coadministered cagrilintide and semaglutide in adults with overweight or obesity. N. Engl. J. Med. 393, 635\u2013647 (2025).","journal-title":"N. Engl. J. Med."},{"key":"1603_CR5","doi-asserted-by":"publisher","first-page":"105862","DOI":"10.1016\/j.ebiom.2025.105862","volume":"118","author":"RE Kuhre","year":"2025","unstructured":"Kuhre, R. E. et al. The effect of amycretin, a unimolecular glucagon-like peptide-1 and amylin receptor agonist, on body weight and metabolic dysfunction in mice and rats. eBioMedicine 118, 105862 (2025).","journal-title":"eBioMedicine"},{"key":"1603_CR6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0140-6736(25)01185-7","volume":"406","author":"K Dahl","year":"2025","unstructured":"Dahl, K. et al. Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b\/2a randomised controlled study. Lancet 406, 149\u2013162 (2025).","journal-title":"Lancet"},{"key":"1603_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1056\/NEJMoa2416394","volume":"393","author":"LJ Aronne","year":"2025","unstructured":"Aronne, L. J. et al. Tirzepatide as compared with semaglutide for the treatment of obesity. N. Engl. J. Med. 393, 26\u201336 (2025).","journal-title":"N. Engl. J. Med."},{"key":"1603_CR8","doi-asserted-by":"publisher","unstructured":"Ludwig, M. Q. et al. A cross-species atlas of the dorsal vagal complex reveals neural mediators of the effects of cagrilintide on energy balance. Nat. Metab. 8, 1350\u20131367 https:\/\/doi.org\/10.1038\/s42255-026-01539-3 (2026).","DOI":"10.1038\/s42255-026-01539-3"},{"key":"1603_CR9","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3389\/fphys.2019.00413","volume":"10","author":"KD Galsgaard","year":"2019","unstructured":"Galsgaard, K. D., Pedersen, J., Knop, F. K., Holst, J. J. & Wewer Albrechtsen, N. J. Glucagon receptor signaling and lipid metabolism. Front. Physiol. 10, 413 (2019).","journal-title":"Front. Physiol."},{"key":"1603_CR10","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.cmet.2022.07.013","volume":"34","author":"T Coskun","year":"2022","unstructured":"Coskun, T. et al. LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: from discovery to clinical proof of concept. Cell Metab. 34, 1234\u20131247.e9 (2022).","journal-title":"Cell Metab."},{"key":"1603_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/nm.3761","volume":"21","author":"B Finan","year":"2015","unstructured":"Finan, B. et al. A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents. Nat. Med. 21, 27\u201336 (2015).","journal-title":"Nat. Med."},{"key":"1603_CR12","doi-asserted-by":"publisher","first-page":"101533","DOI":"10.1016\/j.molmet.2022.101533","volume":"63","author":"PJ Knerr","year":"2022","unstructured":"Knerr, P. J. et al. Next generation GLP-1\/GIP\/glucagon triple agonists normalize body weight in obese mice. Mol. Metab. 63, 101533 (2022).","journal-title":"Mol. Metab."},{"key":"1603_CR13","doi-asserted-by":"publisher","unstructured":"Kleinert, M., Sachs, S., Habegger, K. M., Hofmann, S. M. & M\u00fcller, T. D. Glucagon regulation of energy expenditure. Int. J. Mol. Sci. 20, 5407 https:\/\/doi.org\/10.3390\/ijms20215407 (2019).","DOI":"10.3390\/ijms20215407"},{"key":"1603_CR14","doi-asserted-by":"publisher","first-page":"102027","DOI":"10.1016\/j.molmet.2024.102027","volume":"89","author":"J Petersen","year":"2024","unstructured":"Petersen, J., Merrild, C., Lund, J., Holm, S. & Clemmensen, C. Lead-in calorie restriction enhances the weight-lowering efficacy of incretin hormone-based pharmacotherapies in mice. Mol. Metab. 89, 102027 (2024).","journal-title":"Mol. Metab."},{"key":"1603_CR15","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s42255-025-01324-8","volume":"7","author":"JM Jacobsen","year":"2025","unstructured":"Jacobsen, J. M. et al. CagriSema drives weight loss in rats by reducing energy intake and preserving energy expenditure. Nat. Metab. 7, 1322\u20131329 (2025).","journal-title":"Nat. Metab."},{"key":"1603_CR16","doi-asserted-by":"publisher","unstructured":"Holm, S. K. et al. Sustained weight loss with combined LEAP2 and semaglutide treatment in mice. Diabetes 74, 2089\u20132100 https:\/\/doi.org\/10.2337\/db24-1056 (2025).","DOI":"10.2337\/db24-1056"},{"key":"1603_CR17","doi-asserted-by":"publisher","unstructured":"Petersen, J. et al. GLP-1-directed NMDA receptor antagonism for obesity treatment. Nature 629, 1133\u20131141 https:\/\/doi.org\/10.1038\/s41586-024-07419-8 (2024).","DOI":"10.1038\/s41586-024-07419-8"},{"key":"1603_CR18","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/383175a0","volume":"383","author":"TW Hunt","year":"1996","unstructured":"Hunt, T. W., Fields, T. A., Casey, P. J. & Peralta, E. G. RGS10 is a selective activator of G alpha i GTPase activity. Nature 383, 175\u2013177 (1996).","journal-title":"Nature"},{"key":"1603_CR19","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/ng.883","volume":"43","author":"M Gunay-Aygun","year":"2011","unstructured":"Gunay-Aygun, M. et al. NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet \u03b1-granules. Nat. Genet. 43, 732\u2013734 (2011).","journal-title":"Nat. Genet."},{"key":"1603_CR20","doi-asserted-by":"publisher","first-page":"100027","DOI":"10.1074\/mcp.TIR120.002343","volume":"20","author":"SF Martinez-Huenchullan","year":"2020","unstructured":"Martinez-Huenchullan, S. F. et al. Blockade of high-fat diet proteomic phenotypes using exercise as prevention or treatment. Mol. Cell. Proteomics 20, 100027 (2020).","journal-title":"Mol. Cell. Proteomics"},{"key":"1603_CR21","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1002\/oby.24269","volume":"33","author":"JM Mucinski","year":"2025","unstructured":"Mucinski, J. M., Kelley, D. E., Winters, S. J. & Goodpaster, B. H. Effects of weight loss on testosterone, sex hormone-binding globulin, adiposity, and insulin sensitivity in women and men. Obesity 33, 962\u2013973 (2025).","journal-title":"Obesity"},{"key":"1603_CR22","doi-asserted-by":"publisher","first-page":"100248","DOI":"10.1016\/j.xcrm.2021.100248","volume":"2","author":"J Faramia","year":"2021","unstructured":"Faramia, J. et al. IGFBP-2 partly mediates the early metabolic improvements caused by bariatric surgery. Cell Rep. Med. 2, 100248 (2021).","journal-title":"Cell Rep. Med."},{"key":"1603_CR23","doi-asserted-by":"publisher","unstructured":"Yamashiro, Y. et al. Matrix mechanotransduction mediated by thrombospondin-1\/integrin\/YAP in the vascular remodeling. Proc. Natl Acad. Sci. USA 117, 9896\u20139905 https:\/\/doi.org\/10.1073\/pnas.1919702117 (2020).","DOI":"10.1073\/pnas.1919702117"},{"key":"1603_CR24","doi-asserted-by":"publisher","unstructured":"Masola, V., Bellin, G., Gambaro, G. & Onisto, M. Heparanase: a multitasking protein involved in extracellular matrix (ECM) remodeling and intracellular events. Cells 7, 236 https:\/\/doi.org\/10.3390\/cells7120236 (2018).","DOI":"10.3390\/cells7120236"},{"key":"1603_CR25","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0896-6273(00)80806-5","volume":"23","author":"S Hahm","year":"1999","unstructured":"Hahm, S. et al. Targeted deletion of the Vgf gene indicates that the encoded secretory peptide precursor plays a novel role in the regulation of energy balance. Neuron 23, 537\u2013548 (1999).","journal-title":"Neuron"},{"key":"1603_CR26","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1093\/emboj\/17.12.3277","volume":"17","author":"S Natori","year":"1998","unstructured":"Natori, S. et al. Chromogranin B (secretogranin I), a neuroendocrine-regulated secretory protein, is sorted to exocrine secretory granules in transgenic mice. EMBO J. 17, 3277\u20133289 (1998).","journal-title":"EMBO J."},{"key":"1603_CR27","doi-asserted-by":"publisher","first-page":"7271","DOI":"10.1073\/pnas.0701185104","volume":"104","author":"JW Hewett","year":"2007","unstructured":"Hewett, J. W. et al. Mutant torsinA interferes with protein processing through the secretory pathway in DYT1 dystonia cells. Proc. Natl Acad. Sci. USA 104, 7271\u20137276 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1603_CR28","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/sj.ejhg.5200793","volume":"10","author":"P Rustin","year":"2002","unstructured":"Rustin, P., Munnich, A. & R\u00f6tig, A. Succinate dehydrogenase and human diseases: new insights into a well-known enzyme. Eur. J. Hum. Genetics 10, 289\u2013291 (2002).","journal-title":"Eur. J. Hum. Genetics"},{"key":"1603_CR29","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/s12276-022-00800-5","volume":"54","author":"B Qi","year":"2022","unstructured":"Qi, B. et al. Cardiac-specific overexpression of Ndufs1 ameliorates cardiac dysfunction after myocardial infarction by alleviating mitochondrial dysfunction and apoptosis. Exp. Mol. Med. 54, 946\u2013960 (2022).","journal-title":"Exp. Mol. Med."},{"key":"1603_CR30","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1073\/pnas.1722086115","volume":"115","author":"J He","year":"2018","unstructured":"He, J. et al. Assembly of the membrane domain of ATP synthase in human mitochondria. Proc. Natl Acad. Sci. USA 115, 2988\u20132993 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1603_CR31","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n, M. et al. Tissue-based map of the human proteome. Science 347, 1260419 (2015).","journal-title":"Science"},{"key":"1603_CR32","doi-asserted-by":"publisher","unstructured":"Wewer Albrechtsen, N. et al. 100 years of glucagon and 100 more. Diabetologia 66, 1378\u20131394 https:\/\/doi.org\/10.1007\/s00125-023-05947-y (2023).","DOI":"10.1007\/s00125-023-05947-y"},{"key":"1603_CR33","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/BF00585347","volume":"404","author":"D Butlen","year":"1985","unstructured":"Butlen, D. & Morel, F. Glucagon receptors along the nephron: [125I]glucagon binding in rat tubules. Pflugers Arch 404, 348\u2013353 (1985).","journal-title":"Pflugers Arch"},{"key":"1603_CR34","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1210\/en.2018-00004","volume":"159","author":"LL Baggio","year":"2018","unstructured":"Baggio, L. L. et al. GLP-1 receptor expression within the human heart. Endocrinology 159, 1570\u20131584 (2018).","journal-title":"Endocrinology"},{"key":"1603_CR35","first-page":"F289","volume":"270","author":"PJ Wookey","year":"1996","unstructured":"Wookey, P. J. et al. Amylin binding in rat renal cortex, stimulation of adenylyl cyclase, and activation of plasma renin. Am. J. Physiol. 270, F289\u2013F294 (1996).","journal-title":"Am. J. Physiol."},{"key":"1603_CR36","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1038\/s42255-022-00657-y","volume":"4","author":"L Steuernagel","year":"2022","unstructured":"Steuernagel, L. et al. HypoMap\u2014a unified single-cell gene expression atlas of the murine hypothalamus. Nat. Metab. 4, 1402\u20131419 (2022).","journal-title":"Nat. Metab."},{"key":"1603_CR37","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41586-024-07685-6","volume":"632","author":"K-P Huang","year":"2024","unstructured":"Huang, K.-P. et al. Dissociable hindbrain GLP1R circuits for satiety and aversion. Nature 632, 585\u2013593 (2024).","journal-title":"Nature"},{"key":"1603_CR38","doi-asserted-by":"publisher","unstructured":"Yacawych, W. T. et al. A single dorsal vagal complex circuit mediates the aversive and anorectic responses to GLP1R agonists. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.01.21.634167 (2025).","DOI":"10.1101\/2025.01.21.634167"},{"key":"1603_CR39","doi-asserted-by":"publisher","first-page":"e55851","DOI":"10.7554\/eLife.55851","volume":"9","author":"PN Timshel","year":"2020","unstructured":"Timshel, P. N., Thompson, J. J. & Pers, T. H. Genetic mapping of etiologic brain cell types for obesity. eLife 9, e55851 (2020).","journal-title":"eLife"},{"key":"1603_CR40","doi-asserted-by":"publisher","first-page":"102300","DOI":"10.1016\/j.molmet.2025.102300","volume":"103","author":"NN Aalling","year":"2026","unstructured":"Aalling, N. N. et al. Sustained diabetes remission induced by FGF1 involves a shift in transcriptionally distinct AgRP neuron subpopulations. Mol. Metab. 103, 102300 (2026).","journal-title":"Mol. Metab."},{"key":"1603_CR41","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41588-024-01694-x","volume":"56","author":"Y Zhao","year":"2024","unstructured":"Zhao, Y. et al. Protein-truncating variants in BSN are associated with severe adult-onset obesity, type 2 diabetes and fatty liver disease. Nat. Genet. 56, 579\u2013584 (2024).","journal-title":"Nat. Genet."},{"key":"1603_CR42","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41525-023-00376-7","volume":"8","author":"N Zhu","year":"2023","unstructured":"Zhu, N. et al. Rare predicted loss of function alleles in Bassoon (BSN) are associated with obesity. npj Genom. Med. 8, 33 (2023).","journal-title":"npj Genom. Med."},{"key":"1603_CR43","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature14177","volume":"518","author":"AE Locke","year":"2015","unstructured":"Locke, A. E. et al. Genetic studies of body mass index yield new insights for obesity biology. Nature 518, 197\u2013206 (2015).","journal-title":"Nature"},{"key":"1603_CR44","doi-asserted-by":"publisher","first-page":"101171","DOI":"10.1016\/j.molmet.2021.101171","volume":"47","author":"HH Hansen","year":"2021","unstructured":"Hansen, H. H. et al. Whole-brain activation signatures of weight-lowering drugs. Mol. Metab. 47, 101171 (2021).","journal-title":"Mol. Metab."},{"key":"1603_CR45","doi-asserted-by":"publisher","first-page":"e133429","DOI":"10.1172\/jci.insight.133429","volume":"5","author":"S Gabery","year":"2020","unstructured":"Gabery, S. et al. Semaglutide lowers body weight in rodents via distributed neural pathways. JCI Insight 5, e133429 (2020).","journal-title":"JCI Insight"},{"key":"1603_CR46","doi-asserted-by":"publisher","first-page":"109637","DOI":"10.1016\/j.neuropharm.2023.109637","volume":"238","author":"G Skovbjerg","year":"2023","unstructured":"Skovbjerg, G. et al. Uncovering CNS access of lipidated exendin-4 analogues by quantitative whole-brain 3D light sheet imaging. Neuropharmacology 238, 109637 (2023).","journal-title":"Neuropharmacology"},{"key":"1603_CR47","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","volume":"226","author":"J Folch","year":"1957","unstructured":"Folch, J., Lees, M. & Sloane Stanley, G. H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497\u2013509 (1957).","journal-title":"J. Biol. Chem."},{"key":"1603_CR48","doi-asserted-by":"publisher","unstructured":"Kurgan, N. et al. Body fluid proteomic landscape of acute exercise. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.05.28.656705 (2025).","DOI":"10.1101\/2025.05.28.656705"},{"key":"1603_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60595-7","volume":"16","author":"CC Wu","year":"2025","unstructured":"Wu, C. C. et al. Enrichment of extracellular vesicles using Mag-Net for the analysis of the plasma proteome. Nat. Commun. 16, 5447 (2025).","journal-title":"Nat. Commun."},{"key":"1603_CR50","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1038\/s41556-025-01795-7","volume":"27","author":"A Rai","year":"2025","unstructured":"Rai, A. et al. Multi-omics identify hallmark protein and lipid features of small extracellular vesicles circulating in human plasma. Nat. Cell Biol. 27, 2167\u20132185 (2025).","journal-title":"Nat. Cell Biol."},{"key":"1603_CR51","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41556-021-00693-y","volume":"23","author":"FG Kugeratski","year":"2021","unstructured":"Kugeratski, F. G. et al. Quantitative proteomics identifies the core proteome of exosomes with syntenin-1 as the highest abundant protein and a putative universal biomarker. Nat. Cell Biol. 23, 631\u2013641 (2021).","journal-title":"Nat. Cell Biol."},{"key":"1603_CR52","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"1603_CR53","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu, Z., Eils, R. & Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847\u20132849 (2016).","journal-title":"Bioinformatics"},{"key":"1603_CR54","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"1603_CR55","doi-asserted-by":"publisher","unstructured":"Korotkevich, G. et al. Fast gene set enrichment analysis. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/060012 (2016).","DOI":"10.1101\/060012"},{"key":"1603_CR56","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2009","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2009).","journal-title":"Bioinformatics"},{"key":"1603_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9, 559 (2008).","journal-title":"BMC Bioinformatics"},{"key":"1603_CR58","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.1093\/hmg\/ddy271","volume":"27","author":"L Yengo","year":"2018","unstructured":"Yengo, L. et al. Meta-analysis of genome-wide association studies for height and body mass index in ~700 000 individuals of European ancestry. Hum. Mol. Genet. 27, 3641\u20133649 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"1603_CR59","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41588-017-0011-x","volume":"50","author":"V Turcot","year":"2018","unstructured":"Turcot, V. et al. Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. Nat. Genet. 50, 26\u201335 (2018).","journal-title":"Nat. Genet."}],"container-title":["Nature Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01603-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01603-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01603-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:27:07Z","timestamp":1792668427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01603-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":59,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["1603"],"URL":"https:\/\/doi.org\/10.1038\/s42255-026-01603-y","relation":{},"ISSN":["2522-5812"],"issn-type":[{"value":"2522-5812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"8 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.P., A.B.K. and C.C. are co-founders of Ousia Pharma, a biotech company developing therapeutics for obesity. J.P., C.M. and C.C. are co-founders of Heureka Therapeutics, a biotech company developing therapeutics for cardiometabolic diseases. C.C. has received speaking fees from Novo Nordisk. T.H.P. has received research support from Novo Nordisk, his household holds stocks in Novo Nordisk and has received counselling fees from Eli Lilly and Zealand Pharma. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}